Menu
Recruiting NCT06598657

Talocrural Mobilization With Movement in Spastic Cerebral Palsy

No phase Interventional Spastic Cerebral Palsy (sCP)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mobilization with Movement MWM, Conventional Treatment.
Who it may be relevant to
Registry conditions: Spastic Cerebral Palsy (sCP). Basic parameters: 8 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Talocrural Joint Mobilization With Movement in Spastic Cerebral Palsy Patients

Overview

The aim of this randomized controlled trial is to find the effect of Mulligan's Mobilization with Movement of Talocrural joint in Cerebral Palsy Patients having spasticity on improving Ankle Range of Motion, improving balance and its effect on Gait speed.

Detailed description

Cerebral palsy is a neurodevelopmental disorder involving abnormalities in muscle tone and motor function due to damaged cerebral tissue in development. It is a nonprogressive upper motor neuron lesion characterized by abnormal tone, posture, balance and movement and clinically classified based on the predominant motor syndrome. In spastic CP, there is significant weakness that contributes to abnormal posture and movement. This is also accompanied by decreased muscle endurance and loss of selective motor control (SMC). Spastic diplegia is a very common form of CP, with a wide range of ambulatory outcomes, and is most frequently accompanied by ankle spasticity. Abnormalities, such as excessive plantar flexion of the ankle, leads to individuals with CP have in both static and dynamic balance.

Joint mobilization has not only the mechanical effect of disrupting the contracture by direct movement of the joint area, but also stimulates mechanoreceptor activation when stretching occurs in the capsule and ankle ligaments.

The Mulligan Mobilization with movement (MWM) is a physical therapy technique that combines joint mobilization techniques with active movement. It aims to improve joint range of motion, reduce stiffness, and enhance functional mobility, is expected to produce an instantaneous improvement in the patient's abilities by simultaneous applying of pain-free accessory glides.

This study will contribute in describing long lasting effects of Mobilization With Movement, with multiple assessments, on ankle range of motion, balance, and gait speed, and to check whether the amount of regaining is similar between patients undergoing MWM with conventional therapy and those with conventional therapy alone

Interventions

  • Other Mobilization with Movement MWM
    Mobilization with Movement MWM of Talocrural joint in non-weight bearing position to improve Dorsiflexion Range of Motion (3 sets of 6 repetitions were applied, with a 1-minute break between sets/3 times a week) and conventional therapy which includes stretching, strengthening, balance training exercise.
  • Other Conventional Treatment
    * Stretches of Hamstrings, Gastrocnemius, Soleus and hip adductors with duration of 20 sec hold/ 5 reps and Frequency: 3 times/week. Stretches will be performed passively * Strengthening exercises of Quadriceps and abdominal muscles three times a week. * Static balance exercises including single leg balance, tandem stance, weight shifting with Duration: 10 sec hold/ 5 reps Frequency: 3 times/week

Primary outcome measures

  • Time Up and Go [Time frame: 4 weeks]
  • 10 m WALK TEST [Time frame: 4 weeks]
  • Goniometer [Time frame: 4 weeks]
  • Modified Ashworth Scale (MAS) [Time frame: 4 weeks]

Eligibility criteria

Inclusion criteria

  • Both genders
  • Age group 8-18 years
  • Diagnosis of spastic Cerebral Palsy
  • CP to follow verbal directions
  • Modified Ashworth Scale score of '1' or '1+'
  • Function classification system (GMFCS) level I or II ability to walk
  • 10 m or more independently

Exclusion criteria

  • visual, hearing disorders
  • verbal and cognitive disorders (unable to comprehend commands)
  • recent lower extremity surgery
  • botulinum toxin injection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • PAF School for Persons With special Needs PNS, Islamabad — Islamabad

Identifiers

NCT: NCT06598657 · REC/01877 Maimoona Mubarik

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗